SCHEMBL7359194

SCHEMBL7359194

CC1(C)CC(CC(=O)OCc2ccccc2)CCN1C(=O)CCN

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
CYP2C19 P33261 1/20 0.39
NOTUM Q6P988 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
GLA P06280 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
GRIN2B Q13224 1/20 0.36
HTT P42858 1/20 0.36
TSHR P16473 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790582 0.84 CYP2C19 (0.41) SMN1; SMN2CYP2C19ALDH1A1MAPK1MEN1
SCHEMBL8790127 0.84 CYP2C19 (0.41) SMN1; SMN2CYP2C19ALDH1A1MAPK1MEN1
SCHEMBL8791458 0.81 SMN1; SMN2 (0.50) SMN1; SMN2CYP2C19NOTUMNPC1RAB9A
SCHEMBL10853040 0.74 ALDH1A1 (0.49) SMN1; SMN2CYP2C19NOTUMNPC1RAB9A
SCHEMBL22193270 0.73 LTA4H (0.48) SMN1; SMN2CYP2C19NPC1RAB9AGLA
SCHEMBL4143101 0.72 ALDH1A1 (0.59) SMN1; SMN2CYP2C19NPC1RAB9AGLA
SCHEMBL6627044 0.71 SMN1; SMN2 (0.50) SMN1; SMN2CYP2C19NPC1RAB9AALDH1A1
SCHEMBL7359190 0.71 TMEM97 (0.51) SMN1; SMN2CYP2C19NPC1RAB9AALDH1A1
SCHEMBL7363294 0.70 SMN1; SMN2 (0.48) SMN1; SMN2CYP2C19NPC1RAB9AMEN1
SCHEMBL7363296 0.70 SMN1; SMN2 (0.48) SMN1; SMN2CYP2C19NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996020172-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1996-07-04 WO disclosed